Cue Biopharma, Inc.

CUE XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

130M

Short interest (Jul 15)

7.3%

Net Short (Jul 27 ): 0.2%

Borrow Fee

11.88%

↓ 45.0%

Available Shares

300K

↑ 16.1%

Price Chart

Company Overview

Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001645460

Asset Type: CS

Market Data

Market Cap: $134,915,017

Employees: 29

Status: Active

Short Interest

Current Borrow Fee 11.88%

Range: 11.33% - 11.88%

Available Shares 300K

Range: 250K - 350K

Recent Changes

Fee Change: ↓ 14.5%

Available Change: ↑ 20.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime